Expression Signature as a Biomarker for Prenatal Diagnosis of Trisomy 21

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Volk, Marija ^a   Maver, Aleš ^a   Lovrečić, Luca ^a   Juvan, Peter ^b   Peterlin, Borut ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

AMNION CELL; AREA UNDER THE CURVE; ARTICLE; CELL CULTURE; CHROMOSOME 21; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MACHINE LEARNING; MICROARRAY ANALYSIS; PRENATAL DIAGNOSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTOMICS; TRISOMY 21;

ALGORITHMS; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; FEMALE; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PRENATAL DIAGNOSIS; TRISOMY;

EID: 84884185147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074184     Document Type: Article

References (20)

1. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, et al. (2010) The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol 28: 827-838. doi:10.1038/nbt.1665. PubMed: 20676074.
2. Sotiriou C, Pusztai L, (2009) Gene-expression signatures in breast cancer. N Engl J Med 360: 790-800. doi:10.1056/NEJMra0801289. PubMed: 19228622.
3. Altug-Teber O, Bonin M, Walter M, Mau-Holzmann UA, Dufke A, et al. (2007) Specific transcriptional changes in human fetuses with autosomal trisomies. Cytogenet Genome Res 119: 171-184. doi:10.1159/000112058. PubMed: 18253026.
4. Mao R, Wang X, Spitznagel EL Jr., Frelin LP, Ting JC, et al. (2005) Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol 6: R107. doi:10.1186/gb-2005-6-4-107. PubMed: 16420667.
5. FitzPatrick DR, Ramsay J, McGill NI, Shade M, Carothers AD, et al. (2002) Transcriptome analysis of human autosomal trisomy. Hum Mol Genet 11: 3249-3256. doi:10.1093/hmg/11.26.3249. PubMed: 12471051.
6. Li CM, Guo M, Salas M, Schupf N, Silverman W, et al. (2006) Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet 7: 24. doi:10.1186/1471-2156-7-24. PubMed: 16539728.
7. Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, et al. (2007) Gene expression profiling in the adult Down syndrome brain. Genomics 90: 647-660. doi:10.1016/j.ygeno.2007.08.005. PubMed: 17950572.
8. Prandini P, Deutsch S, Lyle R, Gagnebin M, Delucinge Vivier C, et al. (2007) Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet 81: 252-263. doi:10.1086/519248. PubMed: 17668376.
9. Aït Yahya-Graison E, Aubert J, Dauphinot L, Rivals I, Prieur M, et al. (2007) Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. Am J Hum Genet 81: 475-491. doi:10.1086/520000. PubMed: 17701894.
10. Conti A, Fabbrini F, D'Agostino P, Negri R, Greco D, et al. (2007) Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. BMC Genomics 8: 268. doi:10.1186/1471-2164-8-268. PubMed: 17683628.
11. Vilardell M, Rasche A, Thormann A, Maschke-Dutz E, Pérez-Jurado LA, et al. (2011) Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genomics 12: 229. doi:10.1186/1471-2164-12-229. PubMed: 21569303.
12. Rozovski U, Jonish-Grossman A, Bar-Shira A, Ochshorn Y, Goldstein M, et al. (2007) Genome-wide expression analysis of cultured trophoblast with trisomy 21 karyotype. Hum Reprod 22: 2538-2545. doi:10.1093/humrep/dem214. PubMed: 17635843.
13. Chou CY, Liu LY, Chen CY, Tsai CH, Hwa HL, et al. (2008) Gene expression variation increase in trisomy 21 tissues. Mamm Genome 19: 398-405. doi:10.1007/s00335-008-9121-1. PubMed: 18594911.
14. Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, et al. (2009) Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. Proc Natl Acad Sci U S A 106: 9425-9429. doi:10.1073/pnas.0903909106. PubMed: 19474297.
15. Gudgeon JM, McClain MR, Palomaki GE, Williams MS, (2007) Rapid ACCE: experience with a rapid and structured approach for evaluating gene-based testing. Genet Med 9: 473-478. doi:10.1097/GIM.0b013e3180a6e9ef. PubMed: 17666894.
16. Peng X, Wood CL, Blalock EM, Chen KC, Landfield PW, et al. (2003) Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics 4: 26. doi:10.1186/1471-2105-4-26. PubMed: 12823867.
17. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. doi:10.1006/meth.2001.1262. PubMed: 11846609.
18. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210. doi:10.1093/nar/30.1.207. PubMed: 11752295.
19. Slawski M, Daumer M, Boulesteix AL, (2008) CMA: a comprehensive Bioconductor package for supervised classification with high dimensional data. BMC Bioinformatics 9: 439. doi:10.1186/1471-2105-9-439. PubMed: 18925941.
20. Giannone S, Strippoli P, Vitale L, Casadei R, Canaider S, et al. (2004) Gene expression profile analysis in human T lymphocytes from patients with Down Syndrome. Ann Hum Genet 68: 546-554. doi:10.1046/j.1529-8817.2003.00123.x. PubMed: 15598213.